Clinical Trials Sponsored by Allergan
Total 4268 results
-
AllerganCompletedMacular EdemaFrance, Spain, Belgium, United States, South Africa, Denmark, Netherlands, Israel, Portugal, United Kingdom, Italy, Germany
-
AllerganCompleted
-
AllerganCompletedFacial RhytidesCanada
-
AllerganCompletedOcular Hypertension | Open-angle GlaucomaChina
-
AllerganCompletedContact Lens LubricationUnited States
-
AllerganCompletedDry Eye SyndromesUnited States
-
AllerganCompletedCrow's Feet Lines | Lateral Canthus RhytidesJapan
-
AllerganCompletedMigraine DisordersCanada
-
AllerganCompletedGlabellar LinesGermany
-
AllerganCompletedDiabetic Macular OedemaAustralia
-
AllerganCompletedMigraine, With or Without AuraUnited States
-
AllerganCompleted
-
AllerganTerminatedTemple HollowingUnited States
-
AllerganTerminatedOsteomyelitisUnited States
-
AllerganCompletedLong-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionOcular Hypertension | GlaucomaSpain, France, Belgium, Israel, United Kingdom, Poland, Italy, Czechia, Germany, Hungary
-
AllerganCompletedGlaucoma, Open-Angle | Normal Tension GlaucomaKorea, Republic of
-
AllerganCompleted
-
AllerganCompletedMacular DegenerationUnited States
-
AllerganCompletedHepatic ImpairmentUnited States
-
AllerganCompletedCystitis, Interstitial | Painful Bladder SyndromeUnited States, Canada
-
AllerganCompleted
-
AllerganCompletedFacial Rhytides | Glabellar RhytidesUnited States, Belgium, Germany, United Kingdom
-
AllerganCompleted
-
AllerganCompletedOsteoarthritisCzechia, United States, Denmark
-
AllerganTerminatedStroke | Muscle SpasticityUnited States, Canada
-
AllerganCompleted
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleBrazil
-
AllerganCompletedAndrogenetic AlopeciaUnited States
-
AllerganCompletedUrinary Bladder, Overactive | Urinary Bladder, NeurogenicFrance
-
AllerganCompleted
-
AllerganCompletedMigraine DisordersKorea, Republic of
-
AllerganCompletedMacular DegenerationUnited States
-
AllerganCompletedMacular Edema | Retinal Vein Occlusion | Uveitis, PosteriorFrance, Spain, Germany, United Kingdom
-
AllerganCompletedLateral Canthal Lines | Crow's Feet LinesChina
-
AllerganCompletedMid-face Volume DeficiencyAustralia
-
AllerganCompletedOveractive Bladder | Pharmacokinetics | ElderlyUnited States
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedCervical Dystonia | BlepharospasmUnited Kingdom, Mexico
-
AllerganCompleted
-
AllerganCompletedOveractive BladderPortugal, South Africa, Netherlands, Canada, Singapore, Brazil, United States, Taiwan, Italy, United Kingdom, France, Spain
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleKorea, Republic of
-
AllerganCompletedOcular Hypertension | Open-Angle GlaucomaUnited States
-
AllerganCompletedDry Eye DiseaseFrance, Spain, Russian Federation, Belgium, Germany, Italy, United Kingdom, Australia
-
AllerganCompleted
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleUnited States
-
AllerganCompleted
-
AllerganTerminated
-
AllerganCompletedAcne VulgarisUnited States
-
AllerganCompletedIdiopathic Eyelash HypotrichosisRussian Federation, Sweden, United States, United Kingdom
-
AllerganCompletedGlabellar Lines | Frown Lines | Crow's Feet Lines | Upper Facial RhytidesJapan